Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma
Pancreatology · 2024
DOI: 10.1016/j.pan.2024.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Motonobu Maruo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Peritoneal Lavage, Pancreatectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to evaluate the clinical impact of preoperative endoscopic ultrasound-guided tissue acquisition (EUS-TA) on the prognosis and incidence of positive peritoneal lavage cytology (PLC) during laparotomy or staging laparoscopy in patients with resectable (R) or borderline resectable (BR) pancreatic ductal adenocarcinoma (PDAC). METHODS: We retrospectively collected data from patients diagnosed with body and tail PDAC with/without EUS-TA at our hospital from January 2006 to December 2021. RESULTS: To examine the effect of EUS-TA on prognosis, 153 patients (122 in the EUS-TA group, 31 in the non-EUS-TA group) were analyzed. There was no significant difference in overall survival between the EUS-TA and non-EUS-TA groups after PDAC resection (P = 0.777). In univariate and multivariate analysis, preoperative EUS-TA was not identified as an independent factor related to overall survival after pancreatectomy [hazard ratio 0.96, 95 % confidence interval (CI) 0.54-1.70, P = 0.897]. Next, to examine the direct influence of EUS-TA on the results of PLC, 114 patients (83 in the EUS-TA group and 31 in the non-EUS-TA group) were analyzed. Preoperative EUS-TA was not statistically associated with positive PLC (odds ratio 0.73, 95 % CI 0.25-2.20, P = 0.583). After propensity score matching, overall survival and positive PLC were the same in both groups. CONCLUSIONS: EUS-TA had no negative impact on postoperative survival and PLC-positive rates in R/BR PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
- Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan. Electronic address: ikeurat@hirakata.kmu.ac.jp.
- Cancer Treatment Center, Kansai Medical University, Osaka, Japan.
- Department of Surgery, Kansai Medical University, Osaka, Japan.
- Department of Surgery, Kansai Medical University, Osaka, Japan; Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Zitieren
APA
Maruo, M., Ikeura, T., Takaori, A., Ikeda, M., Nakamaru, K., Ito, T., Masuda, M., Mitsuyama, T., Nakayama, S., Shimatani, M., Takaoka, M., Shibata, N., Boku, S., Yasuda, T., Miyazaki, H., Matsumura, K., Yamaki, S., Hashimoto, D., Satoi, S., & Naganuma, M. (2024). Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma. Pancreatology. https://doi.org/10.1016/j.pan.2024.06.001
Vancouver
Maruo M, Ikeura T, Takaori A, Ikeda M, Nakamaru K, Ito T, et al. Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma. Pancreatology. 2024. doi:10.1016/j.pan.2024.06.001
BibTeX
@article{Maruo2024,
author = {Maruo, Motonobu and Ikeura, Tsukasa and Takaori, Ayaka and Ikeda, Masatoshi and Nakamaru, Koh and Ito, Takashi and Masuda, Masataka and Mitsuyama, Toshiyuki and Nakayama, Shinji and Shimatani, Masaaki and Takaoka, Makoto and Shibata, Nobuhiro and Boku, Shogen and Yasuda, Tomoyo and Miyazaki, Hidetaka and Matsumura, Kazuki and Yamaki, So and Hashimoto, Daisuke and Satoi, Sohei and Naganuma, Makoto},
title = {Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2024.06.001}
}
EUVIMED